Table 2 Changes in clinical parameters, risk factors and lifestyle measures over the study year.
From: Changes in natural killer and T lymphocyte phenotypes in response to cardiovascular risk management
Baseline | Follow-up | Difference | P | |
|---|---|---|---|---|
Clinical data (N, %) | ||||
Weight (kg) | 81.2 (± 15.1) | 80.7 (± 15.0) | − 0.5 (± 2.7) | 0.248 |
Waist (cm) | 100 (± 12.7) | 100 (± 12.2) | − 0.1 (± 3.0) | 0.887 |
BMI | 28.4 (± 4.3) | 28.2 (± 4.6) | + 0.2 (± 1.8) | 0.456 |
Systolic blood pressurea (mmHg) | 150 (± 18) | 143 (± 19) | − 6.3 (± 19.7) | 0.028 |
Diastolic blood pressurea (mmHg) | 84.2 (± 9.2) | 81.1 (± 9.4) | − 3.1 (± 7.7) | 0.006 |
Systolic home pressure (mmHg) | 135 (± 13) | 130 (± 13) | − 4.8 (± 9.9) | 0.010 |
Diastolic home pressure (mmHg) | 76 (± 6) | 74 (± 7) | − 2.2 (± 5.1) | 0.019 |
Frailty score | 3.5 (± 0.6) | 3.4 (± 1.0) | − 0.1 (± 1.0) | 0.673 |
Risk factors (N, %) | ||||
Active smoking | 7 (14) | 6 (12) | − 1 (2) | 0.794 |
Systolic blood pressure > 140 mmHg | 36 (62) | 29 (58) | − 7 (14) | 0.499 |
LDL > 1.8 | 33 (66) | 24 (48) | − 9 (18) | 0.341 |
HbA1c > 53 mmol/mol | 7 (14) | 4 (8) | − 3 (6) | 0.390 |
Levels of physical exercise | ||||
No physical activity | 10 (20) | 14 (28) | + 4 (8) | 0.463 |
Limited physical activity | 27 (54) | 23 (46) | − 4 (8) | 0.644 |
Regular physical exercise | 10 (20) | 11 (22) | + 1 (2) | 0.843 |
Consistent physical exercise | 3 (6) | 2 (4) | − 1 (2) | 0.663 |